Radiation oncology firm Accuray posted lower revenues in its fiscal 2013 financial report (end-June 30).
For the full year, the company's revenue dropped 23% to $315.9 million, compared with $409.2 million in 2012. The company's net loss went from $72 million in the past fiscal year to $103.2 million.
In the fourth quarter, revenue decreased 15% to $84.9 million, compared with $100.5 million in the same quarter of fiscal 2012. The company's net loss for the quarter improved, however, decreasing from $20.2 million last year to $18.7 million in 2013.
